Phosphodiesterase inhibitors: Lily the Pink's medicinal compound for asthma?

Thorax

Volumn 51, Issue 6, 1996, Pages 647-649

  Dent, Gordon ^a   Giembycz, Mark A ^b  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Airway smooth muscle; Inflammatory cells; Phosphodiesterase inhibitors

Indexed keywords

CYCLIC AMP; CYCLIC GMP; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ASTHMA; DRUG EFFECT; DRUG MECHANISM; HUMAN; MUSCLE; PRIORITY JOURNAL; SHORT SURVEY; SMOOTH MUSCLE RELAXATION;

EID: 0029934763     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.6.647     Document Type: Short Survey

References (12)

1. Dent G, Giembycz MA. Selective phosphodiesterase inhibitors in the therapy of asthma. Clin Immunother 1995; 3:423-37.
2. Torphy TJ. Phosphodiesterase isozymes: potential targets for novel antiasthmatic agents. In: Barnes PJ, ed. New drugs for asthma. London: IBC, 1989:66-77.
3. Torphy TJ, Murray KJ, Arch JRS. Selective phosphodiesterase isozyme inhibitors. In: Page CP, Metzger WJ, eds. Drugs and the lung. New York: Raven Press, 1994: 397-447.
4. Sullivan P, Bekir S, Jaffar Z, Page CP, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994;343:1006-8.
5. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KE, Barnes PJ. Immunomodulation by theophylline in asthma. Am J Respir Crit Care Med 1995;151:1907-14.
6. Alvarez R, Sette C, Yang D, Eglen RM, Wilhelm R, Shelton ER, et al. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol Pharmacol, 1995;48:616-22.
7. Rabe KF, Magnussen H, Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J 1995;8:637-42.
8. Cortijo J, Bou J, Beleta J, Cardelús I, Llenas J, Morcillo E, et al. Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br J Pharmacol 1993;108:562-8.
9. Giembycz MA, Souness J. Characteristics and properties of the cyclic AMP-specific phosphodiesterase in eosinophil leukocytes: a potential target for asthma therapy? In: Postma D, Gerritsen J. eds. Bronchitis V: Fifth international symposium. Assen: Van Gorcum, 1994:318-30
10. Verghese MW, McConnell RT, Lenhard JM, Hamacher L, Jin S-LC. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol Pharmacol 1995;47:1164-71.
11. Tenor H, Hatzelmann A, Kupferschmidt R, Stanciu L, Djukanović R, Schudt C, et al. Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages. Clin Exp Allergy 1995;25:625-33.
12. + T lymphocytes. Clin Exp Allergy 1995;25:616-24.